scispace - formally typeset
Open AccessJournal ArticleDOI

Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation.

Reads0
Chats0
TLDR
It is shown that MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner, which may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.
Abstract
The intracellular levels of many proteins are regulated by ubiquitin-dependent proteolysis. One of the best-characterized enzymes that catalyzes the attachment of ubiquitin to proteins is a ubiquitin ligase complex, Skp1-Cullin-F box complex containing Hrt1 (SCF). We sought to artificially target a protein to the SCF complex for ubiquitination and degradation. To this end, we tested methionine aminopeptidase-2 (MetAP-2), which covalently binds the angiogenesis inhibitor ovalicin. A chimeric compound, protein-targeting chimeric molecule 1 (Protac-1), was synthesized to recruit MetAP-2 to SCF. One domain of Protac-1 contains the IκBα phosphopeptide that is recognized by the F-box protein β-TRCP, whereas the other domain is composed of ovalicin. We show that MetAP-2 can be tethered to SCFβ-TRCP, ubiquitinated, and degraded in a Protac-1-dependent manner. In the future, this approach may be useful for conditional inactivation of proteins, and for targeting disease-causing proteins for destruction.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Molecular Strategies to Target Protein Aggregation in Huntington’s Disease

TL;DR: A review of the current state of knowledge of the mRNA targeting approaches such as antisense oligonucleotides and RNAi system; and the novel methods targeting mHTT and aggregates for degradation via the ubiquitin proteasome or the autophagy-lysosomal systems can be found in this paper.
Journal ArticleDOI

Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery.

TL;DR: Proteolysis-targeting chimeras (PROTACs) have been developed to hijack the ubiquitin-proteasome system (UPS) to induce different POIs degradation as mentioned in this paper .
Journal ArticleDOI

Frontiers in PROTACs.

TL;DR: In this paper, the authors discuss some of the most recent innovative concepts emerging from PROTAC research and related technologies, including bifunctional molecules known as proteolysis-targeting chimeras (PROTACs).
Book ChapterDOI

Regulation of Sulfur Metabolism in Mycelial Fungi

TL;DR: The complex regulatory network involved in the control of sulfur metabolism provides a fascinating model for understanding how fungi adjust to a constantly changing nutrient environment in order to maintain sustaining levels of key elements.
Journal ArticleDOI

Progress toward the development of the small molecule equivalent of small interfering RNA.

TL;DR: Several approaches to endow small molecules with the power to cleave RNAs are described, including Inforna, which designs small molecules targeting RNA from human genome sequence and deduces the uniqueness of a druggable pocket.
References
More filters
Journal ArticleDOI

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

TL;DR: Recent progress has been made in understanding the details of the signaling pathways that regulate NF-kappaB activity, particularly those responding to the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1.
Journal ArticleDOI

IKK-1 and IKK-2: Cytokine-Activated IκB Kinases Essential for NF-κB Activation

TL;DR: In this article, a large multiprotein complex, the IkappaB kinase (IKK) signalsome, was purified from HeLa cells and found to contain a cytokine-inducible IKK kinase activity that phosphorylates IappaB-alpha and IKK-beta.
Journal ArticleDOI

SCF and Cullin/RING H2-Based Ubiquitin Ligases

TL;DR: This review is focused on a conserved ubiquitin ligase complex known as SCF that plays a key role in marking a variety of regulatory proteins for destruction by the 26S proteasome.
Journal ArticleDOI

Transduction of full-length TAT fusion proteins into mammalian cells:TAT-p27Kip1 induces cell migration

TL;DR: Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27 Kip1 induces cell migration and promotes cell migration in mice.
Journal ArticleDOI

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

TL;DR: In this article, the authors used biotinylated-epoxomicin as a molecular probe and showed that it covalently binds to the LMP7, X, MECL1, and Z catalytic subunits of the proteasome.
Related Papers (5)